SG11201901917RA - Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance - Google Patents

Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance

Info

Publication number
SG11201901917RA
SG11201901917RA SG11201901917RA SG11201901917RA SG11201901917RA SG 11201901917R A SG11201901917R A SG 11201901917RA SG 11201901917R A SG11201901917R A SG 11201901917RA SG 11201901917R A SG11201901917R A SG 11201901917RA SG 11201901917R A SG11201901917R A SG 11201901917RA
Authority
SG
Singapore
Prior art keywords
international
ampholyte copolymer
mol
pct
cationic
Prior art date
Application number
SG11201901917RA
Inventor
Frédéric Blondel
Emmanuel Aussant
Sandra Guinebretiere
Ian Michael Harrison
Guillaume Jeanson
Original Assignee
Spcm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spcm Sa filed Critical Spcm Sa
Publication of SG11201901917RA publication Critical patent/SG11201901917RA/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87—Polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/654—The particulate/core comprising macromolecular material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Fats And Perfumes (AREA)
  • Polyurethanes Or Polyureas (AREA)

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 22 March 2018 (22.03.2018) WIP0 I PCT omit n OH iolo III ID 111E IIM101101101110 ME (10) International Publication Number WO 2018/050899 A2 (51) International Patent Classification: A61K 8/87 (2006.01) A61Q 19/00 (2006.01) A61K 8/81 (2006.01) A61Q 13/00 (2006.01) A61K 8/11 (2006.01) (21) International Application Number: PCT/EP2017/073518 (22) International Filing Date: 18 September 2017 (18.09.2017) (25) Filing Language: English Published: without international search report and to be republished upon receipt of that report (Rule 48.2(g)) (26) Publication Language: English (30) Priority Data: 16306196.3 19 September 2016 (19.09.2016) EP (71) Applicant: S.P.C.M. SA [FR/FR]; ZAC de Milieux, 42160 ANDREZIEUX BOUTHEON (FR). (72) Inventors: BLONDEL, Frederic; ZAC de Milieux, 42160 ANDREZIEUX BOUTHEON (FR). AUSSANT, Em- manuel; 21 Rue Saint Maur, 75011 PARIS (FR). GUINE- BRETIERE, Sandra; 250 Rue du General Leclerc, 95130 FRANCONVILLE (FR). HARRISON, Ian Michael; 69 Avenue Maurice Berteaux, 78300 POISSY (FR). (74) Agent: DENJEAN, Eric et al.; CABINET LAURENT & CHARRAS, Le Contemporain, 50 Chemin de la Bruyere, 69574 DARDILLY Cedex (FR). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. = (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). * 1 : ) (54) Title: USE OF AN AMPHOLYTE COPOLYMER AS COLLOIDAL STABILIZER IN A PROCESS OF ENCAPSULATING in FRAGRANCE ----. (57) : The invention relates to the use of an ampholyte copolymer as a colloidal stabilizer in the preparation of core-shell microcapsules containing a fragrance, wherein the ampholyte copolymer comprises: - 2 to 99 mol% of cationic monomer having at © least one quaternary ammonium group, - 1 to 98 mol% of acrylic based monomer, - 0 to 97 mol% of non-ionic monomer, and wherein N the ampholyte copolymer has more cationic charges than anionic charges, wherein the cationic charges of the ampholyte copolymer 0 are exclusively due to the at least one quaternary ammonium group of the cationic monomer.
SG11201901917RA 2016-09-19 2017-09-18 Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance SG11201901917RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16306196.3A EP3295929A1 (en) 2016-09-19 2016-09-19 Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance
PCT/EP2017/073518 WO2018050899A2 (en) 2016-09-19 2017-09-18 Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance

Publications (1)

Publication Number Publication Date
SG11201901917RA true SG11201901917RA (en) 2019-04-29

Family

ID=57121167

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201901917RA SG11201901917RA (en) 2016-09-19 2017-09-18 Use of an ampholyte copolymer as colloidal stabilizer in a process of encapsulating fragrance

Country Status (10)

Country Link
US (1) US10758885B2 (en)
EP (2) EP3295929A1 (en)
JP (1) JP6980007B2 (en)
CN (1) CN109789084B (en)
BR (1) BR112019004886B1 (en)
ES (1) ES2846248T3 (en)
MX (1) MX2019002958A (en)
PL (1) PL3515403T3 (en)
SG (1) SG11201901917RA (en)
WO (1) WO2018050899A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201804038D0 (en) * 2018-03-14 2018-04-25 Givaudan Sa Improvements in or realating to organic compounds
CN112004852B (en) * 2018-04-24 2023-04-04 西姆莱斯有限公司 Core-shell capsules prepared with linear and cyclic aliphatic polyisocyanates
CN112725098B (en) * 2020-12-28 2022-04-08 厦门琥珀日化科技股份有限公司 Microcapsule essence laundry detergent and preparation method thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072185C (en) * 1991-06-28 2002-10-01 Shih-Ruey T. Chen Ampholyte terpolymers providing superior conditioning properties in shampoos and other hair care products
JPH05185736A (en) * 1992-01-14 1993-07-27 Fuji Photo Film Co Ltd Production of thermal recording material having small contents of metal ion and halogen ion
JP3208473B2 (en) * 1994-12-15 2001-09-10 ハイモ株式会社 Treatment agent consisting of amphoteric water-soluble polymer dispersion
ATE281235T1 (en) 2000-02-23 2004-11-15 Henkel Kgaa DETERGENT OR CLEANING PRODUCT WITH COMPONENTS IN THE FORM OF MICRO AND/OR NANO CAPSULES
DE10024624A1 (en) 2000-05-18 2001-11-22 Bayer Ag Modified polyisocyanates, e.g. useful in coating compositions, obtained by reacting polyisocyanates with 2-(cyclohexylamino)ethanesulfonic acid and/or 3-(cyclohexylamino)propanesulfonic acid
GB0114197D0 (en) * 2001-06-11 2001-08-01 Syngenta Ltd Reactive polymeric surfactants
EP1396508A1 (en) * 2002-09-04 2004-03-10 Basf Aktiengesellschaft The production of aqueous dispersions of cationic homo- and copolymers using amphoteric protective colloids
US20050112152A1 (en) * 2003-11-20 2005-05-26 Popplewell Lewis M. Encapsulated materials
FR2873579B1 (en) * 2004-07-29 2006-11-03 Oreal COSMETIC COMPOSITION COMPRISING A LINEAR SULFONIC POLYESTER AND A PARTICULAR POLYURETHANE, METHODS USING THE SAME AND USES THEREOF
US8426353B2 (en) 2008-06-16 2013-04-23 Firmenich Sa Process for preparing polyurea microcapsules
US10226405B2 (en) * 2009-09-18 2019-03-12 International Flavors & Fragrances Inc. Purified polyurea capsules, methods of preparation, and products containing the same
US20120148644A1 (en) 2009-09-18 2012-06-14 Lewis Michael Popplewell Encapsulated Active Materials
EP2674477B1 (en) 2010-04-01 2018-09-12 The Procter and Gamble Company Cationic polymer stabilized microcapsule composition
US9271905B2 (en) * 2010-06-11 2016-03-01 Firmenich S.A. Process for preparing polyurea microcapsules
GB201010701D0 (en) * 2010-06-25 2010-08-11 Givaudan Sa Process for producing microcapsules
EP2399667B1 (en) * 2010-06-25 2017-03-08 Cognis IP Management GmbH Process for producing microcapsules
MX361658B (en) * 2013-08-15 2018-12-13 Int Flavors & Fragrances Inc Polyurea or polyurethane capsules.
JP6615121B2 (en) * 2014-04-29 2019-12-04 ビーエーエスエフ ソシエタス・ヨーロピア Method for producing microcapsules
WO2015197757A1 (en) * 2014-06-27 2015-12-30 Firmenich Sa Hybrid perfume microcapsules
KR20170078805A (en) 2014-11-07 2017-07-07 바스프 에스이 Microcapsules comprising hydroxyalkyl cellulose

Also Published As

Publication number Publication date
US20190255501A1 (en) 2019-08-22
EP3515403B1 (en) 2021-01-13
CN109789084B (en) 2022-03-08
JP2019530566A (en) 2019-10-24
CN109789084A (en) 2019-05-21
BR112019004886A2 (en) 2019-06-11
WO2018050899A3 (en) 2019-04-25
WO2018050899A2 (en) 2018-03-22
JP6980007B2 (en) 2021-12-15
BR112019004886B1 (en) 2022-07-12
EP3295929A1 (en) 2018-03-21
EP3515403A2 (en) 2019-07-31
US10758885B2 (en) 2020-09-01
PL3515403T3 (en) 2021-06-14
ES2846248T3 (en) 2021-07-28
MX2019002958A (en) 2019-07-04

Similar Documents

Publication Publication Date Title
SG11201908813QA (en) Anti-sirp alpha antibodies
SG11201909949XA (en) Targeted immunotolerance
SG11201811431VA (en) Multispecific antibodies against cd40 and cd137
SG11201907056XA (en) Compositions and methods for the treatment of hemoglobinopathies
SG11201806340YA (en) Zika virus vaccine
SG11201801401UA (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
SG11201811706RA (en) Process for the preparation of microcapsules
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201908977SA (en) Niraparib formulations
SG11202000136YA (en) Preparation comprising vonoprazan
SG11202000333UA (en) Bicyclic ketone compounds and methods of use thereof
SG11201804916PA (en) Three-dimensional polymer networks with channels situated therein
SG11201808713YA (en) Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier
SG11201809830WA (en) Selective reduction of cysteine-engineered antibodies
SG11201808686VA (en) Synthesis of indazoles
SG11201907364WA (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
SG11201906041QA (en) Pharmaceutical compositions for combination therapy
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201903061YA (en) Combination treatments comprising administration of imidazopyrazinones
SG11201809497RA (en) Processes for preparing phosphorodiamidate morpholino oligomers
SG11201901438VA (en) Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate
SG11201901394XA (en) Neisseria meningitidis vaccine
SG11201809875VA (en) Compositions and methods for treating spinal muscular atrophy
SG11201809561WA (en) 9-aminomethyl minocycline compounds and methods of use thereof in urinary tract infection (uti) treatment
SG11201805649UA (en) Therapeutic anti-cd9 antibody